Trevi Therapeutics stock hits all-time high at 19.33 USD
AI Summary
Trevi Therapeutics stock hit an all-time high at 19.33 USD, indicating heightened investor interest and confidence in the biotechnology sector.
Related Articles
Asia stocks climb as chipmakers rebound on AI spending hopes despite Iran tensions
Investing.com —
AI is turning film scripts into pitch trailers
Economic Times India —
Drax Power Station’s Carbon Emissions Hit A New High In 2025 While Receiving Record Public Subsidies
CleanTechnica —
Malaysia’s growth expected to hold at 4-5pc despite external uncertainties, says BNM governor
Malay Mail —
Oil heads for weekly gain as Middle East supply risks persist
Channel NewsAsia —
株価 一時1600円超値上がり AI・半導体中心に買い注文広がる
NHK World —